CIM
CIM Investment Management Portfolio holdings
AUM
$525M
This Quarter Return
-5.89%
1 Year Return
+18.97%
3 Year Return
+87.66%
5 Year Return
+127.31%
10 Year Return
+233.62%
AUM
$296M
AUM Growth
+$296M
(-11%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-7.37%
Top 10 Holdings %
Top 10 Hldgs %
47.05%
Holding
319
New
20
Increased
47
Reduced
180
Closed
70
Top Buys
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$3.64M |
| 2 |
NVIDIA
NVDA
|
$2.38M |
| 3 |
Under Armour
UAA
|
$1.4M |
| 4 |
Meta Platforms (Facebook)
META
|
$1.18M |
| 5 |
Netflix
NFLX
|
$1.12M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$7.83M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$2.42M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$1.72M |
| 4 |
Live Nation Entertainment
LYV
|
$1.58M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
$1.11M |
Sector Composition
| 1 | Technology | 17.54% |
| 2 | Consumer Discretionary | 9.57% |
| 3 | Healthcare | 7.77% |
| 4 | Financials | 7.75% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Protolabs
PRLB
$1.17B
| $213K | 0.07% |
4,028
-469
| -10% | -$24.8K |
|
227
Brink's
BCO
$4.65B
| $209K | 0.07% |
3,074
-3,800
| -55% | -$258K |
|
228
First Commonwealth Financial
FCF
$1.83B
| $209K | 0.07% |
13,761
-1,600
| -10% | -$24.3K |
|
229
Zurn Elkay Water Solutions
ZWS
$7.52B
| $209K | 0.07% |
5,895
-686
| -10% | -$24.3K |
|
230
Ingevity
NGVT
$2.1B
| $206K | 0.07% |
3,214
-373
| -10% | -$23.9K |
|
231
First Financial Bankshares
FFIN
$5.21B
| $204K | 0.07% |
4,631
-539
| -10% | -$23.7K |
|
232
Halozyme
HALO
$8.64B
| $204K | 0.07% |
5,108
-604
| -11% | -$24.1K |
|
233
Blackstone Mortgage Trust
BXMT
$3.31B
| $203K | 0.07% |
6,387
-741
| -10% | -$23.6K |
|
234
HUB Group
HUBG
$2.26B
| $203K | 0.07% |
2,624
-306
| -10% | -$23.7K |
|
235
FibroGen
FGEN
$48.8M
| $202K | 0.07% |
16,765
-1,951
| -10% | -$23.5K |
|
236
Stratasys
SSYS
$868M
| $202K | 0.07% |
7,961
-925
| -10% | -$23.5K |
|
237
ALX Oncology
ALXO
$55.2M
| $181K | 0.06% |
+10,706
| New | +$181K |
|
238
Amicus Therapeutics
FOLD
$2.38B
| $181K | 0.06% |
19,082
-2,222
| -10% | -$21.1K |
|
239
Atomera
ATOM
$99.8M
| $180K | 0.06% |
13,813
-1,609
| -10% | -$21K |
|
|
QUOT
240
DELISTED
Quotient Technology Inc
QUOT
| $162K | 0.05% |
25,370
-2,944
| -10% | -$18.8K |
|
241
Skillz
SKLZ
$134M
| $158K | 0.05% |
52,672
+14,829
| +39% | +$44.5K |
|
242
TG Therapeutics
TGTX
$4.68B
| $143K | 0.05% |
+14,986
| New | +$143K |
|
243
Pacific Biosciences
PACB
$378M
| $142K | 0.05% |
+15,582
| New | +$142K |
|
244
vTv Therapeutics
VTVT
$47.1M
| $115K | 0.04% |
158,915
-18,458
| -10% | -$13.4K |
|
245
Workhorse Group
WKHS
$19.4M
| $114K | 0.04% |
22,778
-2,643
| -10% | -$13.2K |
|
246
GrowGeneration
GRWG
$98M
| $112K | 0.04% |
12,161
-1,412
| -10% | -$13K |
|
247
Opko Health
OPK
$1.1B
| $112K | 0.04% |
32,668
-3,818
| -10% | -$13.1K |
|
248
Bionano Genomics
BNGO
$18.6M
| $69K | 0.02% |
26,657
-3,235
| -11% | -$8.37K |
|
|
DHC
249
Diversified Healthcare Trust
DHC
$910M
| $42K | 0.01% |
13,229
-1,536
| -10% | -$4.88K |
|
250
AbbVie
ABBV
$374B
| – | – |
-5,099
| Closed | -$690K |
|